La cadena de opciones muestra datos clave de las opciones de acciones de CDT Equity a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para CDT Equity..

CDT Equity (NASDAQ:CDT) Bolsa, Cadena de Opciones

Conduit Pharmaceuticals

CDT Equity Inc, formerly Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ACON

ACTG

ALUR

BTAI

CNTA

DALN

DWTX

EVAX

FFBC

HYZN

LITM

MLYS

NVNI

PBBK

SEPN

STBX

TRUG

TWLO

Twilio sube un 18,5% tras superar expectativas de ingresos. Explora los movimientos clave del mercado previo de hoy.

Acciones de Twilio (TWLO) se disparan más de un 18%; 20 acciones que se mueven en el premercado de EE.UU.

AMPG

AREB

BHAT

BWMN

CALM

DATS

DRIO

EONR

GRFX

HOTH

JBDI

LAES

RGTI

RIME

SANA

SLDB

SVMH

XTIA

Movimientos destacados del premercado: Cal-Maine Foods sube un 3,8%, Sana Biotechnology lidera con un 220,6%.

Las acciones de Cal-Maine Foods suben un 4%; Aquí están 20 acciones que se mueven en el premercado

CDT Equity Inc

Infinitii Ai Inc

CDT Environmental Technology Investment Holdings Limited - ordinary shares

CDT Environmental Technology Investment Holdings Ltd

CDTI ADVANCED MATERIALS by CDTI Advanced Materials, Inc.

CDTi Advanced Materials Inc

Cidara Therapeutics Inc

CDT Equity Inc. Quarterly Report (Form10) (Amended)

CDT Equity Inc. Quarterly Report (Form10)

CDT Equity Inc. (FormSCHEDULE 13G) (Amended)

Health Care

Press Releases

CDT Equity Identifies New Biological Target Validating AI-Driven Repurposing Strategy

Biotech

General

CDT Equity Identifies New Biological Target And Therapeutic Use For AZD1656 Through AI-Driven Drug Repurposing

CDT Equity identifies new biological target for AZD1656

CDT Equity Inc. Changes to Beneficial Ownership: Lewis-Hall Freda C (Director) (Form4)

CDT Equity Inc. Changes to Beneficial Ownership: Farley Chele Chiavacci (Director) (Form4)

CDT Equity Inc. Changes to Beneficial Ownership: Fry Simon Jeremy (Director) (Form4)

Comments

CDT Equity

CDT Equity (CDT) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL